FDA Approved: TEZRULY — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved TEZRULY (terazosin) under ANI Pharmaceuticals' original NDA, bringing terazosin to market under a new brand for approved indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Hypertension

Drugs mentioned

• TEZRULY (TERAZOSIN)

Snippet

ORIG AP for TEZRULY (TERAZOSIN)